Profile
Michael A.
Shia worked as an Immunology Director at 21st Century Biochemicals, Inc., a Principal at Boston University, and a Principal at PathoGenetix, Inc. He earned a doctorate degree from Boston University in 1984.
Former positions of Michael A. Shia
Companies | Position | End |
---|---|---|
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology PathoGenetix, Inc. operates as a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. Its Genome Sequence Scanning technology isolates and analyzes DNA from an enriched biological sample, without the need for a cultured isolate. The firm specializes in food safety, industrial microbiology, and clinical diagnostics and research. The company was founded in 1997 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - |
Boston University | Corporate Officer/Principal | - |
21st Century Biochemicals, Inc.
21st Century Biochemicals, Inc. Chemicals: Major DiversifiedProcess Industries 21st Century Biochemicals LLC develops chemical compounds. It manufactures amino acid peptides which are used in preparation of medicine. The company supplies products to the pharmaceutical companies. 21st Century Biochemicals was founded by Jordan B. Fishman in 2003 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
Training of Michael A. Shia
Boston University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
21st Century Biochemicals, Inc.
21st Century Biochemicals, Inc. Chemicals: Major DiversifiedProcess Industries 21st Century Biochemicals LLC develops chemical compounds. It manufactures amino acid peptides which are used in preparation of medicine. The company supplies products to the pharmaceutical companies. 21st Century Biochemicals was founded by Jordan B. Fishman in 2003 and is headquartered in Marlborough, MA. | Process Industries |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology PathoGenetix, Inc. operates as a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. Its Genome Sequence Scanning technology isolates and analyzes DNA from an enriched biological sample, without the need for a cultured isolate. The firm specializes in food safety, industrial microbiology, and clinical diagnostics and research. The company was founded in 1997 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Michael A. Shia